Published in Radiology on February 01, 2002
Influence of computer-aided detection on performance of screening mammography. N Engl J Med (2007) 8.58
Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst (2004) 4.07
Effectiveness of computer-aided detection in community mammography practice. J Natl Cancer Inst (2011) 3.62
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
The ACR BI-RADS experience: learning from history. J Am Coll Radiol (2009) 2.68
Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst (2007) 1.95
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Probabilistic computer model developed from clinical data in national mammography database format to classify mammographic findings. Radiology (2009) 1.65
Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance? AJR Am J Roentgenol (2010) 1.49
Applications and literature review of the BI-RADS classification. Eur Radiol (2005) 1.36
Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004. Radiology (2010) 1.24
Reality check: perceived versus actual performance of community mammographers. AJR Am J Roentgenol (2006) 1.20
The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions. Manuf Serv Oper Manag (2012) 1.08
The positive predictive value of the breast imaging reporting and data system (BI-RADS) as a method of quality assessment in breast imaging in a hospital population. Eur Radiol (2004) 1.05
The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool. Eur Radiol (2012) 1.03
The mammographic density of a mass is a significant predictor of breast cancer. Radiology (2010) 1.00
Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667. Radiology (2010) 1.00
Timeliness of follow-up after abnormal screening mammogram: variability of facilities. Radiology (2011) 0.98
Accuracy of short-interval follow-up mammograms by patient and radiologist characteristics. AJR Am J Roentgenol (2008) 0.95
Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography. J Natl Cancer Inst (2010) 0.95
Delay in diagnostic testing after abnormal mammography in low-income women. Oncol Nurs Forum (2009) 0.94
Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers. AJR Am J Roentgenol (2015) 0.88
Predictors of interobserver agreement in breast imaging using the Breast Imaging Reporting and Data System. Breast Cancer Res Treat (2010) 0.85
Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol (2014) 0.81
Breast imaging reports for malignant lesions: are we maintaining recommended BI-RADS(®) lexicon standards? Cancer Manag Res (2012) 0.78
A history of breast cancer and older age allow risk stratification of mammographic BI-RADS 3 ratings in the diagnostic setting. Clin Imaging (2015) 0.78
The influence of mammographic technologists on radiologists' ability to interpret screening mammograms in community practice. Acad Radiol (2014) 0.78
Overdiagnosis and overtreatment of breast cancer: is overdiagnosis an issue for radiologists? Breast Cancer Res (2006) 0.78
Positive predictive value of mammography: comparison of interpretations of screening and diagnostic images by the same radiologist and by different radiologists. AJR Am J Roentgenol (2010) 0.77
Observer Variability of the Breast Imaging Reporting and Data System (BI-RADS) Lexicon for Mammography. Breast Care (Basel) (2010) 0.77
Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target. Oncotarget (2015) 0.77
Second Opinion Assessment in Diagnostic Mammography at a Breast Cancer Centre. Geburtshilfe Frauenheilkd (2012) 0.75
Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice. AJR Am J Roentgenol (2016) 0.75
How to improve your breast cancer program: Standardized reporting using the new American College of Radiology Breast Imaging-Reporting and Data System. Indian J Radiol Imaging (2009) 0.75
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol (2009) 9.39
Influence of computer-aided detection on performance of screening mammography. N Engl J Med (2007) 8.58
Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol (2003) 8.25
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol (2003) 7.68
The case for early detection. Nat Rev Cancer (2003) 6.96
Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med (2004) 6.42
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol (2007) 6.11
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature (2008) 5.98
Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08
A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain. Arch Intern Med (2009) 4.96
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer (2007) 4.76
Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA (2003) 4.54
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med (2015) 4.53
Performance benchmarks for screening mammography. Radiology (2006) 4.41
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res (2003) 4.13
Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst (2004) 4.07
Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med (2006) 3.95
Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology (2003) 3.90
Combination anastrozole and fulvestrant in metastatic breast cancer. N Engl J Med (2012) 3.86
Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst (2004) 3.86
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75
Effectiveness of computer-aided detection in community mammography practice. J Natl Cancer Inst (2011) 3.62
Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst (2010) 3.53
Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. J Natl Cancer Inst (2009) 3.48
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell (2007) 3.44
Association of volume and volume-independent factors with accuracy in screening mammogram interpretation. J Natl Cancer Inst (2003) 3.41
Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer (2003) 3.25
Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst (2005) 3.06
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance. Cancer Res (2008) 3.05
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
Physical activity levels among breast cancer survivors. Med Sci Sports Exerc (2004) 2.88
Body mass and weight change in adults in relation to mortality risk. Am J Epidemiol (2013) 2.87
Association between mammography timing and measures of screening performance in the United States. Radiology (2005) 2.85
Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology (2009) 2.78